(Q40010307)

English

Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma

scientific article published on 21 February 2008

Statements

Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma (English)
Mithat Gonen
Jeffrey R Gardner
Jill Mastrella
Dajun Yang
Jon Holmlund
Mel Sorensen
Lance Leopold
Katia Manova
Mark L Heaney
21 February 2008
5350-5358

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit